10-Q: DT Cloud Star Q1 2026 Financial Results & SPAC Update

DT Cloud Star Acquisition Corporation reports Q1 2026 financial results while navigating a Nasdaq listing deficiency and pending business combination with PrimeGen US, Inc.

Summary

• Reported a net loss of $110,289 for the three months ended March 31, 2026, compared to a net income of $630,284 in the same period of 2025.
• Operating expenses for the quarter were $268,316, primarily driven by formation and administrative costs.
• Cash and marketable securities held in the Trust Account totaled $18,259,482 as of March 31, 2026.
• The company entered into a Business Combination Agreement with PrimeGen US, Inc. on February 2, 2026.
• Working capital deficit stood at $854,550 as of March 31, 2026, excluding deferred underwriting commissions.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a high-risk situation due to the combination of a net loss, working capital deficit, going concern warning, and a Nasdaq delisting threat.

Positives

• Successfully entered into a definitive Business Combination Agreement with PrimeGen US, Inc.
• Maintained trust account assets of over $18.2 million to support the proposed business combination.
• Secured extensions to the business combination deadline to allow more time for transaction completion.

Negatives

• Reported a net loss for the quarter compared to a profit in the prior year period.
• Significant working capital deficit raises concerns regarding liquidity.
• Received a Nasdaq deficiency notice regarding the minimum public shareholder requirement.
• Substantial doubt exists regarding the company's ability to continue as a going concern.

Risks

• Failure to regain compliance with Nasdaq Listing Rule 5450(a)(2) could lead to delisting.
• Inability to consummate the proposed business combination with PrimeGen US, Inc. by the extended deadline.
• Potential for further redemptions of public shares to negatively impact liquidity.
• Reliance on the Sponsor for additional funding via promissory notes to sustain operations.

Future Outlook

The company is focused on consummating the business combination with PrimeGen US, Inc. and addressing the Nasdaq listing deficiency. Management plans to issue additional promissory notes to the Sponsor to fund ongoing operations until the transaction closes.

Management Comments

• Management believes the proposed business combination will provide an operating business and additional capital resources.
• Management is actively managing cash resources to meet the minimum cash condition required for the business combination.
• The company is evaluating strategic alternatives, including a potential transfer to the Nasdaq Capital Market, to address listing compliance.

Industry Context

StockSavvy.ai notes that this filing reflects the ongoing challenges faced by SPACs in the current market, specifically regarding liquidity, the pressure to close deals before liquidation deadlines, and the increasing frequency of Nasdaq compliance issues for smaller SPACs.

Comparison to Industry Standards

• The company's reliance on sponsor loans for working capital is standard for SPACs in the pre-combination phase.
• The use of extensions to the business combination deadline is a common practice among SPACs struggling to find or close targets within initial timeframes.
• The Nasdaq deficiency notice is a recurring issue for SPACs that have experienced high redemption rates, reducing their public float.

Legal Proceedings

• None reported.

Related Party Transactions

• Promissory notes issued to the Sponsor for working capital.
• Administrative services agreement with an affiliate of the Sponsor for $10,000 per month.

Stakeholder Impact

• Shareholders face uncertainty regarding the completion of the business combination and the potential for Nasdaq delisting.
• The Sponsor remains the primary source of liquidity, creating a dependency that could influence future deal terms.

Next Steps

• Submit a compliance plan to Nasdaq by May 21, 2026.
• Continue efforts to consummate the business combination with PrimeGen US, Inc.
• Monitor liquidity and secure additional funding from the Sponsor as needed.

Key Dates

Recommendation

The combination of a going concern warning, a Nasdaq delisting notice, and a significant working capital deficit makes this a high-risk investment with limited visibility on a successful business combination.

Keywords

SPAC, Business Combination, Nasdaq, PrimeGen US, Going Concern, 10-Q